A recent study from The Massachusetts Institute of Technology in Cambridge revealed just 18 percent of American studies on how to improve healthcare use the “random assignment” method, compared to 41 percent of studies outside the U.S.
“Randomized trials are critical because they enable researchers to isolate the effects of a treatment or program, such as a drug or a visit from a home health aide,” the article states. “They ensure that a change was due to the treatment or service and not some other factor.”
Some feel random assignment trials are time-consuming and expensive, MIT professor and an author of the study, Amy Finkelstein, PhD, told The Times. However, she said there are ways around this, and conversely, random assignment trials could save the industry billions in the long run.
More articles on leadership and management:
5 traits of uniquely charismatic leaders
Changing your leadership style in 4 steps
The best of Quint Studer: 10 must-read insights for healthcare leaders
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
